EVOLUTION OF IDEAS ABOUT THE ROLE OF VITAMINS AND SUPPLEMENTS IN THE DIET OF PATIENTS WITH CANCER
DOI:
https://doi.org/10.32782/2077-6594.4.1.2021.246990Keywords:
dietary supplements, vitamins, oncological diseases, preventionAbstract
Given the huge prevalence of cancer in the world and in Ukraine, their prevention is one of the most urgent tasks of modern medicine. Today, the possibility of preventing colon cancer by reducing the consumption of red meat and increasing dietary fiber is being actively studied. Another area is the preventive use of dietary supplements, certain vitamins and their complexes. The article presents the main observations conducted in the world over the past 15-20 years, which studied the effectiveness of dietary supplements in the diet of patients for the prevention of cancer and pre-existing diseases as adjuvant therapy.
References
Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M, Malinge S, Yao J, Kilpivaara O, Bhat R, et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood. 2009;114: 144–147.
Lawrence H. et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention. https://onlinelibrary.wiley.com/doi/full/ 10.3322/caac.20140.
An J, González-Avalos E, Chawla A, Jeong M, López-Moyado IF, Li W, Goodell MA, Chavez L, Ko M, Rao A. Acute loss of TET function results in aggressive myeloid cancer in mice. Nat Commun. 2015;6:10071.
Chen Q., Espey M.G., Sun A.Y., Pooput C., Kirk K.L., Krishna M.C., Khosh D.B., Drisko J., Levine M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc. Natl. Acad. Sci. USA. 2008;105:11105–11109. doi: 10.1073/pnas.0804226105.
Cameron E., Pauling L. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc. Natl. Acad. Sci. USA. 1976;73:3685–3689. doi: 10.1073/pnas.73.10.3685.
Bober P., Alexovic M., Talian I., Tomkova Z., Viscorova Z., Benckova M., Andrasina I., Ciccocioppo R., Petrovic D., Adamek M., et al. Proteomic analysis of the vitamin C effect on the doxorubicin cytotoxicity in the MCF-7 breast cancer cell line. J. Cancer Res. Clin. Oncol. 2017;143:35–42. doi: 10.1007/s00432-016-2259-4.
Cameron E., Campbell A. The orthomolecular treatment of cancer. Ii. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem. Biol. Interact. 1974;9:285–315. doi: 10.1016/0009-2797(74)90019-2.
Kimmie Ng. et al. Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer. JAMA. 2019;321(14):1370-1379.
Gwendolyn N.Y. et al. The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review. Nutrients. 2019 May; 11(5): 977.
Joshua D. et al. O2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate. Cancer Cell.Volume 31, Issue 4, 10 April 2017, 487-500.
Lippman S.M., Klein E.A., Goodman P.J. et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers // JAMA. – 2009. – Vol. 301. – P. 39-51.
Poulter J.M., White W.F., Dickerson J.W. Ascorbic acid supplementation and five year survival rates in women with early breast cancer. Acta. Vitaminol. Enzymol. 1984;6:175–182.
Riordan H.D., Casciari J.J., Gonzalez M.J., Riordan N.H., Miranda-Massari J.R., Taylor P., Jackson J.A. A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. Puerto Rico Health Sci. J. 2005;24:269–276.
Takahashi H.M.H., Ynagisawa A. High-dose intravenous vitamin C improves quality of life in cancer patients. Pers. Med. Univ. 2012;1:49–53. doi: 10.1016/j.pmu.2012.05.008.
Tanvetayanon T., Bepler G. Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers // Cancer. – 2008. – Vol. 113. – P. 150-157.
Mitsuyoshi Urashima. Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers. JAMA. 2019;321(14):1361-1369.
Vollbracht C et al. Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany. In Vivo. 2011 Nov-Dec; 25(6):983-90.
Wypych T.P/. Marsland B.J. Diet hypothesis in light of the microbiota revolution: new perspectives //Nutrients. – 2017. – Vol.9. – P.537-544.
Yeom C.H., Jung G.C., Song K.J. Changes of terminal cancer patients’ health-related quality of life after high dose vitamin C administration. J. Korean Med. Sci. 2007;22:7–11. doi: 10.3346/jkms.2007.22.1.7
Zhao H., Zhu H., Huang J., Zhu Y., Hong M., Zhu H., Zhang J., Li S., Yang L., Lian Y., et al. The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia. Leuk. Res. 2018;66:1–7. doi: 10.1016/j.leukres.2017.12.009.
Creagan E.T., Moertel. C.G., O’Fallon J.R., Schutt A.J., O’Connell M.J., Rubin J., Frytak S. Failure of high-dose vitamin c (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N. Engl. J. Med. 1979;301: 687–690. doi: 10.1056/NEJM197909273011303.
